Objectivity Squared LLC Purchases Shares of 3,397 Danaher Corporation $DHR

Objectivity Squared LLC purchased a new stake in Danaher Corporation (NYSE:DHR) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 3,397 shares of the conglomerate’s stock, valued at approximately $2,446,000. Danaher makes up approximately 1.4% of Objectivity Squared LLC’s investment portfolio, making the stock its 10th biggest holding.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Pallas Capital Advisors LLC acquired a new stake in shares of Danaher in the 2nd quarter valued at approximately $641,000. Performance Wealth Partners LLC acquired a new position in Danaher during the second quarter worth $342,000. Deutsche Bank AG acquired a new position in Danaher during the second quarter worth $446,265,000. Perigon Wealth Management LLC bought a new stake in Danaher during the second quarter worth $968,000. Finally, Commerzbank Aktiengesellschaft FI acquired a new stake in Danaher in the second quarter valued at $609,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on DHR shares. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. TD Cowen reduced their price target on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Morgan Stanley lowered their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, UBS Group dropped their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Danaher Stock Down 0.0%

Shares of DHR opened at $202.44 on Tuesday. The firm has a market cap of $142.31 billion, a P/E ratio of 35.96, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm’s 50-day simple moving average is $193.52 and its 200 day simple moving average is $192.67.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same period last year, the business posted $0.77 earnings per share. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. On average, analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.